by Lexplosion | Nov 2, 2022 | Central, Clinical establishments, OPS | 0 comments New Drugs and Clinical Trials Rules amended to introduce deemed approval for conducting clinical trials You need to be logged in to view this content. Please Log In. Not a Member? Join Us Share this: Share Tweet Pin LinkedIn Related Posts:Amendments underway to the Drugs Rules; proposes…Health Ministry notifies the Drugs (3rd Amendment)…Union Health Ministry mandates registration of…DCGI specifies select countries for considering… centralClinical EstablishmentsOperations Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
